Literature DB >> 10899941

Neurite outgrowth induced by a synthetic peptide ligand of neural cell adhesion molecule requires fibroblast growth factor receptor activation.

L C Rønn1, P Doherty, A Holm, V Berezin, E Bock.   

Abstract

The neural cell adhesion molecule NCAM is involved in axonal outgrowth and target recognition in the developing nervous system. In vitro, NCAM-NCAM binding has been shown to induce neurite outgrowth, presumably through an activation of fibroblast growth factor receptors (FGFRs). We have recently identified a neuritogenic ligand, termed the C3 peptide, of the first immunoglobulin (lg) module of NCAM using a combinatorial library of synthetic peptides. Here we investigate whether stimulation of neurite outgrowth by this synthetic ligand of NCAM involves FGFRs. In primary cultures of cerebellar neurons from wild-type mice, the C3 peptide stimulated neurite outgrowth. This response was virtually absent in cultures of cerebellar neurons from transgenic mice expressing a dominant-negative form of the FGFR1. Likewise, in PC12E2 cells transiently expressing a dominant-negative form of the mouse FGFR1, induction of neurites by the C3 peptide was abrogated. These findings suggest that the neuritogenic effect of the C3 peptide requires the presence of functional FGFRs and support the hypothesis that FGFRs are essential in cell adhesion molecule-stimulated neurite outgrowth. The C3 peptide appears to stimulate neurite outgrowth by specifically activating an NCAM-FGFR-dependent signaling cascade and may therefore be of considerable interest as a tool for the determination of NCAM-dependent neurite outgrowth as well as a potential drug capable of promoting outgrowth and regeneration of NCAM-responsive axons.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10899941     DOI: 10.1046/j.1471-4159.2000.0750665.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  12 in total

1.  Analysis of non-canonical fibroblast growth factor receptor 1 (FGFR1) interaction reveals regulatory and activating domains of neurofascin.

Authors:  Katja Kirschbaum; Martin Kriebel; Eva Ursula Kranz; Oliver Pötz; Hansjürgen Volkmer
Journal:  J Biol Chem       Date:  2009-08-07       Impact factor: 5.157

Review 2.  Intracellular signaling by the neural cell adhesion molecule.

Authors:  Gro Klitgaard Povlsen; Dorte Kornerup Ditlevsen; Vladimir Berezin; Elisabeth Bock
Journal:  Neurochem Res       Date:  2003-01       Impact factor: 3.996

3.  IL-1beta-induced pro-apoptotic signalling is facilitated by NCAM/FGF receptor signalling and inhibited by the C3d ligand in the INS-1E rat beta cell line.

Authors:  L G Petersen; J Størling; P Heding; S Li; V Berezin; J Saldeen; N Billestrup; E Bock; T Mandrup-Poulsen
Journal:  Diabetologia       Date:  2006-05-23       Impact factor: 10.122

4.  Fibroblast growth factor receptor 3-IIIc mediates colorectal cancer growth and migration.

Authors:  G Sonvilla; S Allerstorfer; C Heinzle; S Stättner; J Karner; M Klimpfinger; F Wrba; H Fischer; C Gauglhofer; S Spiegl-Kreinecker; B Grasl-Kraupp; K Holzmann; M Grusch; W Berger; B Marian
Journal:  Br J Cancer       Date:  2010-03-16       Impact factor: 7.640

5.  A peptide motif from the second fibronectin module of the neural cell adhesion molecule, NCAM, NLIKQDDGGSPIRHY, is a binding site for the FGF receptor.

Authors:  Jacob Jacobsen; Vladislav Kiselyov; Elisabeth Bock; Vladimir Berezin
Journal:  Neurochem Res       Date:  2008-03-27       Impact factor: 3.996

Review 6.  NCAM Mimetic Peptides: Potential Therapeutic Target for Neurological Disorders.

Authors:  Chengyan Chu; Yue Gao; Xiaoyan Lan; Aline Thomas; Shen Li
Journal:  Neurochem Res       Date:  2018-07-12       Impact factor: 3.996

Review 7.  Neuritogenic and neuroprotective properties of peptide agonists of the fibroblast growth factor receptor.

Authors:  Shizhong Li; Elisabeth Bock; Vladimir Berezin
Journal:  Int J Mol Sci       Date:  2010-05-26       Impact factor: 5.923

Review 8.  FGF/FGFR signaling in health and disease.

Authors:  Yangli Xie; Nan Su; Jing Yang; Qiaoyan Tan; Shuo Huang; Min Jin; Zhenhong Ni; Bin Zhang; Dali Zhang; Fengtao Luo; Hangang Chen; Xianding Sun; Jian Q Feng; Huabing Qi; Lin Chen
Journal:  Signal Transduct Target Ther       Date:  2020-09-02

Review 9.  NCAM mimetic peptides: Pharmacological and therapeutic potential.

Authors:  Vladimir Berezin; Elisabeth Bock
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 2.866

10.  Pharmacology of cell adhesion molecules of the nervous system.

Authors:  Darya Kiryushko; Elisabeth Bock; Vladimir Berezin
Journal:  Curr Neuropharmacol       Date:  2007-12       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.